The therapeutic potential of inducing molecules

Bibliography

• OGAWA M: Differentiation and proliferation of he- matopoietic stem cells. Blood (1993) 81:2844–2853.
   PubMed Web of Science ®Google Scholar
• JACOBSON LO, GOLDWASSER LF, FRIED W, PLZAK L: Role of the kidney in erythropoiesis. Nature (1957) 179:633-634. This paper presented the first evidence that the kidneys produce erythropoietin in response to anaemia.
   Google Scholar
• STEPHENSON JR, AXELROD AA, MCLEOD DL, SHREVE MM: Induction of hemoglobin-synthesizing cells by erythro- poietin in vitro. Proc. Natl. Acad. Sci. USA (1971) 65:1542–1546.
   Web of Science ®Google Scholar
• KOURY MJ, BONDURANT MC: Erythropoietin retards DNA breakdown and prevents programmed cell death in erythriod progenitor cells. Science (1990) 248:378–381.
   PubMed Web of Science ®Google Scholar
• ERSLEV AJ, CARO J, KANSU E, SILVER R: Renal and extrarenal erythropoietin production in anaemic rats. Br. HaemaL (1980) 45:65–72.
   PubMed Web of Science ®Google Scholar
• ERSLEV AJ: Renal biogenesis of erythropoietin. Am. J. Med. (1975) 58:25–30.
   PubMed Web of Science ®Google Scholar
• ERSLEV AJ, CARO J, MILLER O, SILVER R: Plasma erythro- poietin in health and disease. Ann. Clin. Lab. Sci. (1980) 10:250–257.
   PubMed Web of Science ®Google Scholar
• SCHUREK HJ, JOST U, BERTRAM H, BAUMGART L:Periglomerular cortical oxygen diffusion shunt: a pre- requisite for effective erythropoietin regulation. In: Erythropoietin; from Molecular Structure to Clinical Applica- tion (Vol. 76), Baldamus CA, Scigalla P, Wieczorek L, Koch KM (Eds.), Basel, Karger (1989):57–66.
   Google Scholar
• SEMENZA GL, WANG GL: A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol. Cell. Biol. (1992) 12:5447–5454.
   PubMed Web of Science ®Google Scholar
• WANG GL, SEMENZA GL: General involvement of hy- poxia-inducible factor 1 in transcriptional response to hypoxia. Proc. Natl. Acad. Sci. USA (1993) 90:4304–4308.
   PubMed Web of Science ®Google Scholar
• ESSERS U: Use of erthyropoietin in the treatment of patients with anemia of renal insufficiency. American SocieW of Hematology, Chicago, Illinois, (December 1–4, 1973).
   Google Scholar
• WINEARLES CG, OLIVER DO, PIPPARD MJ eta].: Effect of human erythropoietin derived from recombinant DNA on the anaemia of patients maintains by chronic haemodialysis. Lancet (1986) 2:1175–1178.
   Google Scholar
• ESCHBACH JW, EGRIE JC, DOWNING MR, BROWNE JK,ADAMSON JW: Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of combined Phase I & II clinical trials. NewEngl. J. Med. (1987) 316:73–78.
   Google Scholar
• MACDOUGALL IC: How to get the best out of r-HuEPO. Nephrol Dial. Transplant (1995) 10\(Suppl. 2):85–91.
   Google Scholar
• GOTTLIEB RA, GIESING HA, ZHU JY, ENGLER RL, BABIORBM: Cell acidification in apoptosis: granulocyte colony- stimulating factor delays programmed cell death in neutrophils by up-regulating the vacuole r H(+)-ATPase. Proc. Natl. Acad. Sci. USA (1995) 92:5965–5968.
   PubMed Web of Science ®Google Scholar
• COLOTTA F, RE F, POLENTARUTTI N, SOZZANI S, MAN-TOVANI A: Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products. Blood (1992) 80:2012–2924.
   PubMed Web of Science ®Google Scholar
• SPIEKERMANN K, ROESLER J, EMMENDOERFFER A, ELSNER
   Google Scholar
• •J. WELTE K: Functional features of neutrophils induced by G-CSF and GM-CSF treatment: differential effects and clinical applications. Leukemia (1997) 11:466-478. Comprehensive review of the functional effects of G-CSF on neutro-phils in patients receiving G-CSF therapy.
   Google Scholar
• MASSAGUE J: The transforming growth factor-beta family. Ann. Rev. Cell Biol. (1990) 6:597-641. Extensive review of the TGF-I3 superfamily including structure, expression, regulation, biological effects and identified receptors.
   Google Scholar
• KINGSLEY DM: The TGF-B superfamily: new members, new receptors, and new genetic tests of finction in different organisms. Genes Dev. (1994) 8:133–146.
   PubMed Web of Science ®Google Scholar
• HOGAN BLM: Bone morphogenetic proteins: multifunctional regulators of vertebrate development. Genes Dev. (1996) 10:1580-1594. Excellent review of BMPs and their role in the development of various vertebrate organs and tissues.
   Google Scholar
• REDDI AH: Cell biology and biochemistry of endochon- dral bone development. Collagen Rel. Res. (1981) 1:209–226.
   PubMedGoogle Scholar
• LUYTEN FP, CUNNINGHAM NS, MA S et al: Purificationand partial amino acid sequence of osteogenin, a pro- tein initiating bone differentiation. J. Biol. Chem. (1989) 264:13377–13380.
   PubMed Web of Science ®Google Scholar
• WANG EA, ROSEN V, CORDES P eta].: Purification and characterization of other distinct bone-inducing fac- tors. Proc. Natl. Acad. Sci. USA (1988) 85:9484–9488. 50.
   Google Scholar
• KAPLAN FS, TABAS JA, ZASLOFF MA: Fibrodysplasia ossi- ficans progressive: a clue form the fly? Ca'cif Tissue Int (1990) 47:117–125.
   PubMed Web of Science ®Google Scholar
• RAO VV, LOFFLER C, WOZNEYJM, HANSMANN I: The gene for bone morphogenetic protein 2A (BMP2A) is local-ized to human chromosome 20P12 by radioactive and non-radioactive in situ hybridization. Hum. Genet (1992) 90:299–302.
   PubMed Web of Science ®Google Scholar
• URIST MR, NAKAGAAWAA M, NAKATA N: Experimental myositis ossificans. Arch. Pathol Lab. Med. (1978) 102:312–316.
   PubMed Web of Science ®Google Scholar
• YOSHIKAWA H, RETTIG WJ, TAKAOKA K et al.: Expres- sion of bone morphogenetic proteins in human osteosarcoma. Immunohistochemical detection with monoclonal antibody. Cancer (1994) 73:85–91.
   Google Scholar
• YAMAGUCHI A, KATAGIRI T, IKEDA T et aL: Recombinant human bone morphogenetic protein-2 stimulates osteoblastic maturation and inhibited myogenic differ- entiation in vitro. Cell Biol. (1991) 113:681–687.
   PubMed Web of Science ®Google Scholar
• WOZNEY JM: The bone morphogenetic protein family and osteogenesis. Mol. Reprod. Dev. (1992) 32:160–167.
   PubMed Web of Science ®Google Scholar
• YASKO AW, LANE JM, FELLINGER EF etal.: The healing of segmental defects, induced by recombinant human bone morphogenetic protein (rhBMP-2). A radio-graphic, histological, and biomechanical study in rats. J. Bone Joint Surg. (1992) 74A:659–670.
   Google Scholar
• OZKAYNAK E, SCHNEGELSBERG PNJ, OPPERMANN H: Murine osteogenic protein-1 (0P-1): high levels of mRNA in kidney. Biochem. Biophys. Res. Commun. (1991) 179:116–123.
   PubMed Web of Science ®Google Scholar
• OZKAYNAK E, SCHNEGELSBERG PNJ, JIN DF etal: Osteo- genic protein-2: a new member of the transforming growth factor-13 superfamily expressed in early em- bryogenesis. J Biol. Chem. (1992) 267:25220–25227.
   PubMed Web of Science ®Google Scholar
• MALIAKAL JC, ASAHINA I, HAUSCHKA PV, SAMPATH TK: Osteogenic protein-1 (BM1 3 7) inhibits cell proliferation and stimulates the expression of markers characteristic of osteoblast phenotype in rat osteosarcoma cells. Growth Factors (1994) 11:227–234.
   PubMed Web of Science ®Google Scholar
• SAMPATH TK MALIAKAL JC, HAUSCHKA PV et al.: Recom- binant human osteogenic protein-1 (hop-1) induces new bone formation in vivo with a specific activity comparable with natural bovine osteogenic protein and stimulates osteoblast proliferation and differentiation in vitro. J. Biol. Chem. (1992) 267:20352–20362.
   PubMed Web of Science ®Google Scholar
• COOK SD, RUEGER, DC: Osteogenic protein-1: biology and applications. Clin. Orthop. Rel. Res. (1996) 324:29-38. A review of recent in vivo animal studies using recombinant human OP-1 in bone formation.
   Google Scholar
• COOK SD, BAFFES GC, WOLFE MW, SAMPATH TK, RUEGER DC: Recombinant human bone morphogenic protein-7 induces healing in a canine long bone segmental defect model. Clin. Orthop. (1994) 301:302–312.
   PubMed Web of Science ®Google Scholar
• COOK SD, WOLFE MW, SALKELD SL, RUEGER, DC:Recom-binant human osteogenic protein-1 (rhOP-1) heals seg- mental defects in nonhuman primates. J. Bone JointSurg. (1995) 77A:734–750.
   Web of Science ®Google Scholar
• COOK SD, DALYON JE, TAN EH, WHITECLOUD TS, RUEGER DC: In vivo evaluation of recombinant human osteogenic protein (rhOP-1) implants as bone graft substitute for spinal fusions. Spine (1994) 19(1.9: 1655–1663.
   Google Scholar
• COOK SD, SALKELD SL, RUEGER DC: Evaluation of osteo- genic protein-1 to aid in the initial fixation of implants. J. Oral Implantol. (1996) 21:1–6.
   Google Scholar
• UNSICKER K: GDNF: a cytokine at the interface ofTGF-Bs and neurotrophins. Cell Tissue Res. (1996) 286:175–178.
   PubMed Web of Science ®Google Scholar
• TRUPP M, RYDEN M, JORNVALL H et al.: Peripheral expression and biological activites of GDNF, a new neurotrophic factor for avian and mammalian periph- eral neurons. J. Cell Biol. (1995) 130:137–148.
   PubMed Web of Science ®Google Scholar
• CHOI-LUNDBERG DL, BOHN MC: Ontogeny and distribu- tion of gli a cell line-derived neurotrophic factor (GDNF) mRNA in rat. Dev. Brain Res. (1995) 85:80–88.
   PubMedGoogle Scholar
• UN L-FH, DOHERTY DH, LILE JD, BEKTESH S, COLLINS F:
   Google Scholar
• •GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science (1993) 260:1130-1132. The purification and cloning of GDNF based on its ability to promote survival and differentiation of midbrain dopaminergic neurones is presented in this paper.
   Google Scholar
• SANCHEZ MP, SILOS-SANTIAGO I, FRISEN J et al.: Renal agenesis and the absence of enteric neurons in mice lacking GDNF. Nature (1996) 382:70–73.
   PubMed Web of Science ®Google Scholar
• PICHEL JG, SHEN L, SHENG HZ et al.: Defects in enteric innervation and kidney development in mice lacking GDNF. Nature (1996) 382:73–76.
   PubMed Web of Science ®Google Scholar
• MOORE MW, KLEIN RD, FARINAS I et al: Renal and neuronal abnormalities in mice lacking GDNF. Nature (1996) 382:76–79.
   PubMed Web of Science ®Google Scholar
• LINDSAY RM: Neuron saving schemes. Nature (1995) 373:289–290.
   PubMed Web of Science ®Google Scholar
• LAPCHAK PA, GASH DM, RAO S, MILLER PJ, HILT D: Glial cell line-derived neurotrophic factor: a novel therapeu-tic approach to treat motor dysfunction in Parkinson's disease. Exp. Neurol. (1997) 144:29–34.
   PubMed Web of Science ®Google Scholar
• BECK KD, VALVERDE J, ALEXI et al.: Mesencephalic dopaminergic neurons protected by GDNF from axo- tomy-induced degeneration in the adult brain. Nature (1995) 373:339-341. Data presented in this study indicated that direct intraparenchymal injections of GDNF attenuated the loss of tyrosine-hydroxylase expressing neurones in the substantia nigra after axotomy.
   Google Scholar
• TOMAC A, LINDQVIST E, LIN L-FH et al: Protection and repair of the nigrostriatal thpaminergic system by GDNF in vivo. Nature (1995) 373:335-339. This study provided substantial evidence that GDNF not only protects dopamine neurones in animal models of Parkinson's dis-ease, but can induce regeneration of tyrosine-hydroxylase im-munoreactive fibres after a toxic insult.
   Google Scholar
• OPPENHEIM RW, HOUENOU LJ, JOHNSON JE et al: Devel- oping motor neurons rescued from programmed and axotomy-induced cell death by GDNF. Nature (1995) 373:344–346.
   PubMed Web of Science ®Google Scholar
• LEVI-MONTALCINI R: Developmental neurobiology and the natural history of nerve growth factor. Ann. Rev. Neurosci. (1982) 5:341–362.
   PubMed Web of Science ®Google Scholar
• SNIDER WD: Functions of neurotrophins during nervous system development: what the knockouts are teach-ing us. Cell (1994) 77:627-638. Excellent review of the specific neuronal losses in neurotrophin and neurotrophin receptor gene deleted mice.
   Google Scholar
• JOHNSON JR EM, GORIN PD, BRANDEIS LD, PEARSON J: Dorsal root ganglion neurons are destroyed by expo-sure in utero to maternal antibody to nerve growth factor. Science (1980) 210:916–918.
   PubMed Web of Science ®Google Scholar
• CROWLEY C, SPENCER SD, NISHIMURA MC et al: Mice lacking nerve growth factor display perinatal loss of sensory and sympathetic neurons yet develop basal forebrain cholinergic neurons. Cell (1994) 76:1001–1011.
   PubMed Web of Science ®Google Scholar
• ANAND P: Neurotrophins and peripheral neuropathy. Phil. Trans. Royal Soc. Lond. B (1996) 351:449–454.
   PubMed Web of Science ®Google Scholar
• TOMLINSON DR, FERNYHOUGH P, DIEMEL LT: Neurotro-phins and peripheral neuropathy. Phil. Trans. R. Soc. Lond. B (1996) 351:455–462.
   PubMed Web of Science ®Google Scholar
• MCMAHON SB, PRIESTLEY JV: Peripheral neuropathies and neurotrophic factors: animal models and clinical perspectives. Curr. Opin. Neurobiol (1995) 5:616–624.
   PubMed Web of Science ®Google Scholar
• ANAND P, RUDGE P, MATHIAS CJ eta].: A new autonomic and sensory neuropathy with loss of adrenergic sym-pathetic function and sensory neuropeptides. Lancet (1991) 337:1353–1355.
   Google Scholar
• PIRART J: Diabetes mellitus and its degenerative compli-cations: a prospective study of 4,400 patients observed between 1947 and 1973. Diab. Care (1978) 1:168–188.
   Google Scholar
• ROGERS BC: Development of recombinant human nerve growth factor (rhNGF) as a treatment for periph-eral neuropathic disease. Neurotoxicology (1996) 17:865–870.
   PubMed Web of Science ®Google Scholar
• EATON DL, DE SAUVAGE, FJ: Thrombopoietin: the pri-mary regulator of megakaryocytopoiesis and throm-bopoiesis. Exp. Hematol. (1997) 25:1–7.
   PubMed Web of Science ®Google Scholar
• KUTER DJ: Thrombopoietin: biology, clinical applica-tions, role in the donor setting. J. Clin. Apheresis (1996) 11:149–159.
   PubMed Web of Science ®Google Scholar
• GURNEY AL, CARVER-MOORE K, DE SAUVAGE FJ, MORREMW: Thrombocytopenia in c-mpl-deficient mice. Sci-ence (1994) 265:1445–1447.
   PubMed Web of Science ®Google Scholar
• DE SAUVAGE FJ, CARVER-MOORE K, LUOH S-M et al: Physiological regulation of early and late stages of megakaryocytopoiesis by thrombopoietin. J. Exp. Med. (1996) 183:651–656.
   PubMed Web of Science ®Google Scholar
• FIELDER PJ, GURNEY AL, STEFANICH E et al: Regulation of thrombopoietin levels by c-mpl-mediated binding to platelets. Blood (1996) 87:2154–2161.
   PubMed Web of Science ®Google Scholar
• BASSER R, CLARKE K, FOX R et al: Randomized, doubleblind, placebo controlled Phase I trial of pegylated me gakaryocyt e growth and development factor admin-istered to patients with advanced cancer before and after chemotherapy-early results. Blood (1995) 86\(Suppl. 0:257.
   Google Scholar
• HAMMERSCHMIDT M, BROOK A, MCMAHON AP: The world according to hedgehog. Trends Genet (1997) 13:14-21. Review of the Hedgehog gene family expression and function in vertebrates and invertebrates, processing and potential signalling mechanisms.
   Google Scholar
• PORTER JA, YOUNG KE, BEACHY PA: Cholesterol modi- ?fication of hedgehog signaling proteins in animal de-velopment. Science (1996) 274:255-259. This biochemical study demonstrated an essential role for cholesterol in Hedgehog autoprocessing.
   Google Scholar
• KELLEY RL, ROESSLER E, HENNEKAM RC et al: Holo- prosencephaly in RSH/Smith-Lemli-Opitz syndrome: does abnormal cholesterol metabolism affect the func-tion of Sonic hedgehog? Am. J. Med. Genet (1996) 66:478–484.
   Web of Science ®Google Scholar
• VORTKAMP A, LEE K, LANSKE B eta].: Regulation of rate of cartilage differentiation by Indian hedgehog and PTH-related protein. Science (1996) 273:613–622.
   Google Scholar
• ROELINK H, PORTER JA, CHIANG C eta].: Floorplate and motor neuron induction by different concentrations of the amino-terminal cleavage product of Sonic hedge-hog. Cell (1995) 81:445-455. This study demonstrated concentration dependent induction of specific cell types by Shh.
   Google Scholar
• WANG MZ, JIN P, BUMCROT DA et al: Induction ofdopaminergic neuron phenotype in the midbrain by Sonic hedgehog protein. Nature Med. (1995) 1:1184–1188.
   PubMed Web of Science ®Google Scholar
• HYNES M, PORTER JA, CHIANG C et al: Induction ofmidbrain dopaminergic neurons by Sonic hedgehog. Neuron (1995) 15:35–44.
   PubMed Web of Science ®Google Scholar
• ERICSON J, MUHR J, PLACZEK M et al.: Sonic hedgehog induces the differentiation of ventral forebrain neu-rons: a common signal for ventral patterning within the neural tube. Cell (1995) 81:747–756.
   PubMed Web of Science ®Google Scholar
• CHIANG C, LITINGTUNG Y, LEE E et al.: Cyclopia and defective axial patterning in mice lacking Sonic hedge-hog gene function. Nature (1996) 383:407-413. This study described the extensive abnormalities in the CNS and limbs of Shh genetically deleted mice, including the absence of specific cell types and structures.
   Google Scholar
• BELLONI E, MUENKE M, ROESSLER E et al. Identification of Sonic hedgehog as a candidate gene responsible for holoprosencephaly. Nature Genet. (1996) 14:353–356.
   PubMed Web of Science ®Google Scholar
• ROESSLER E, BELLONI E, GAUDENZ K et al.: Mutations in the human Sonic hedgehog gene cause holo-prosencephaly. Nature Genet (1996) 14:357–360.
   PubMed Web of Science ®Google Scholar
• OLANOW CW, KORDOWER JH, FREEMAN TB: Fetal nigral transplantation as a therapy for Parkinson's disease. Trends Neurosci. (1996) 19:102–109.
   PubMed Web of Science ®Google Scholar
• WALLIS GA: Bone growth: coordinating chondrocytedifferentiation. Curr. Biol. (1996) 6:1577–1580.
   PubMed Web of Science ®Google Scholar
• LANSKE B, KARAPLIS AC, LEE K eta].: PTH/PTHrP receptor in early development and Indian hedgehog-related bone growth. Science (1996) 273:663–666.
   Google Scholar
• BIT GOOD MJ, SHEN L, MCMAHON AP: Sertoli cell signaling by Desert hedgehog regulates the male germline. Curr. Biol. (1996) 6:298-304. This paper described the complete lack of mature sperm in male mice lacking Dhh gene function
   Google Scholar
• STONE DM, HYNES M, ARMANINI M eta].: The tumor-sup-pressor gene Patched encodes a candidate receptor for Sonic hedgehog. Nature (1996) 384:129-134. The series of in vitro and biochemical experiments presented in this paper suggest that patched is a Hedgehog receptor. Additional evidence is presented that smoothened, a potential G-protein cou-pled receptor, is also involved in Hedgehog signalling.
   Google Scholar
• MARIGO V, DAVEY RA, ZUO Y, CUNNINGHAM JM, TABIN
   Google Scholar
• •CJ: Biochemical evidence that Patched is the hedgehog receptor. Nature (1996) 384:176-179. This paper also presented a series of biochemical experiments that indicate patched as a potential Hedgehog receptor.
   Google Scholar
• JOHNSON RL, ROTHMAN AL, XIE J eta].: Human homologof Patched, a candidate gene for the basal cell nevus syndrome. Science (1996) 272:1688–1671.
   Google Scholar
• HAHN H, WICKING C, ZAPHIROPOULOS PG eta].: Muta-tions of the human homolog of Drosophila Patched in the nevoid basal cell carcinoma syndrome. Cell (1996) 85:841–851.
   Google Scholar